XDND:XETRA:XETRA-Xtrackers MSCI North America High Dividend Yield UCITS ETF 1C (EUR)

ETF | Others |

Last Closing

USD 47.795

Change

+0.09 (+0.19)%

Market Cap

N/A

Volume

5.13K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.48 (-1.07%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+3.47 (+3.93%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.04 (-0.18%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.01 (-0.05%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.01 (+0.14%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.10 (+0.46%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.12 (+1.02%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.92 (+1.64%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.03 (+0.28%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.16 (+0.13%)

USD 12.26B

ETFs Containing XDND:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.98% 29% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.98% 32% F 32% F
Trailing 12 Months  
Capital Gain -0.63% 30% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.63% 33% F 37% F
Trailing 5 Years  
Capital Gain 53.43% 55% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 53.43% 56% F 55% F
Average Annual (5 Year Horizon)  
Capital Gain 12.42% 75% C 74% C
Dividend Return 12.42% 75% C 72% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.84% 58% F 66% D+
Risk Adjusted Return 114.61% 96% N/A 96% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike